微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.74% | -38.04% | 81.61% | 16/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 2.61% | -39.72% | 99.24% | 19/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.31% | -27.22% | -83.05% | 20/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 7.73% | -31.17% | 1.05% | 17/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 7.65% | -37.75% | 76.67% | 16/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 4.33% | -67.39% | 140.56% | 20/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 1.8% | -68.8% | -83.97% | 23/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 11.23% | -55.67% | -8.62% | 19/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 12.29% | 2% | -7.45% | 17/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 13.28% | -6.48% | 130.16% | 6/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 5.77% | 2% | -77.22% | 6/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 25.33% | -3.14% | 78.38% | 7/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-06-30 | 14.2% | -14.3% | -45.7% | 8/51 | 2.28% | 金域医学 | 43.58% | 行业排名> |
| 2020-12-31 | 26.15% | -35.16% | 57.82% | 8/51 | 10.95% | 金域医学 | 35.41% | 行业排名> |
| 2020-06-30 | 16.57% | 2% | -58.91% | 3/51 | 2.48% | 阳光诺和 | 26.2% | 行业排名> |
| 2019-12-31 | 40.33% | 12.65% | 12.65% | 6/51 | 65.31% | 金域医学 | 13.23% | 行业排名> |
| 2018-12-31 | 35.8% | 14.19% | 14.19% | 3/51 | -0.6% | 万邦医药 | 52.05% | 行业排名> |
| 2017-12-31 | 31.35% | 2% | 2% | 2/51 | 1.73% | 华大基因 | 48.52% | 行业排名> |